ベンチャー探訪 Pahr Therapeutics社、肺動脈性肺高血圧症にAHRを制御する治療薬を開発へ | AN Venture Partners

ベンチャー探訪 Pahr Therapeutics社、肺動脈性肺高血圧症にAHRを制御する治療薬を開発へ

MediaPortfolio Companies

ベンチャー探訪 Pahr Therapeutics社、肺動脈性肺高血圧症にAHRを制御する治療薬を開発へ

September 26, 2025

Typewriter Therapeutics Emerges from Stealth with $56 Million Series A Financing to pursue in vivo CAR T medicines

Press Release

Portfolio Companies

Typewriter Therapeutics Emerges from Stealth with $56 Million Series A Financing to pursue in vivo CAR T medicines

Cambridge, Mass., September 2, 2026

Crystalys Therapeutics Closes $130 Million Series B Funding to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout

Press Release

Portfolio Companies

Crystalys Therapeutics Closes $130 Million Series B Funding to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout

San Diego, July 23, 2026

Privacy Policy

This website uses Google Analytics cookies for access analysis only. The collected data is used solely for improving the website and is handled appropriately. By clicking "AGREE", you consent to the use of cookies.

Privacy Policy

This website uses Google Analytics cookies for access analysis only. The collected data is used solely for improving the website and is handled appropriately. By clicking "AGREE", you consent to the use of cookies.